ASTRAZENECA CZECH REPUBLIC S.R.O. AND/ASupply Agreement • August 9th, 2022
Contract Type FiledAugust 9th, 2022This agreement (“Supply Agreement”) is made between: (1) (1) AstraZeneca Czech Republic s.r.o., having its registered seat at the address U Trezorky 921/2, Jinonice, 158 00 Praha 5, registered in the Commercial Register administered by the Municipal Court in Prague, Section C, Record 38105, Business ID No.: 639 84 482, Tax IN No.: CZ63984482, Bank details: CITIBANK Europe Plc, Bucharova 264/14, 158 02 Praha 5 Account No.:204 164 0206/2600, represented by Kuuno Vaher, executive (“AstraZeneca”); and Fakultní nemocnice Olomoucwith its registered office at I.P. Pavlova 185/6, 77900 Olomoucrepresented by: prof. MUDr. Roman Havlík, Ph.D., directorID No.: 00098892Tax ID No.: CZ00098892Bank connection: Česká národní banka (2) Account No.: 36334811/0710 (the“Purchaser”), (each a “Party”, and collectively the “Parties”). INTRODUCTION (A) AstraZeneca is actively pursuing the clinical development of the Product in order to file for and secure the Regulatory Approval before the Licensing Authority.